FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older Posted on July 29, 2022July 10, 2023 by fraziermwd
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners Posted on May 9, 2022July 10, 2023 by fraziermwd
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults Posted on May 3, 2022July 10, 2023 by fraziermwd
HilleVax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Posted on May 3, 2022July 10, 2023 by fraziermwd
GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn Posted on April 13, 2022July 10, 2023 by fraziermwd
Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis Posted on January 25, 2022July 10, 2023 by fraziermwd
